FCCRX | SWCAX | FCCRX / SWCAX | |
Total Expense Ratio | 0.46 | 0.38 | 121% |
Annual Report Gross Expense Ratio | 0.52 | 0.41 | 127% |
Fund Existence | 8 years | 34 years | - |
Gain YTD | 0.436 | -0.296 | -147% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.32B | 467M | 282% |
Annual Yield % from dividends | 3.39 | 3.27 | 104% |
Returns for 1 year | 0.61 | 0.03 | 2,162% |
Returns for 3 years | 6.19 | 6.97 | 89% |
Returns for 5 years | -1.44 | -0.99 | 146% |
Returns for 10 years | N/A | 12.20 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CZAR | 32.21 | N/A | N/A |
Themes Natural Monopoly ETF | |||
CPSF | 24.93 | N/A | N/A |
Calamos S&P 500 Str Alt Prt ETF-Feb | |||
MLPB | 25.75 | -0.09 | -0.36% |
UBS ETRACS Alerian MLPInfrs ETN SerB | |||
BMEZ | 14.18 | -0.09 | -0.63% |
BlackRock Health Sciences Term Trust | |||
RSEE | 31.69 | -0.24 | -0.75% |
Rareview Systematic Equity ETF |